Literature DB >> 8052138

Insulin dissociates hepatic glucose cycling and glucagon-induced thermogenesis in man.

J Calles-Escandón1.   

Abstract

The quantitative contribution of hepatic glucose cycling to basal and glucagon-stimulated thermogenesis was investigated in seven normal healthy volunteers in whom energy expenditure (EE) was measured simultaneously with indirect calorimetry. Primed-constant infusions of 2-(2H1)-glucose and 6-6'-(2H2)-glucose were used to calculate hepatic glucose cycling. Gas chromatography/mass spectrometry was used to measure the plasma enrichment of isotopes. In response to hyperglucagonemia, basal EE increased an average of 7.1% +/- 2.3% (P < .05). This thermogenic effect of glucagon was completely blunted when insulin levels were increased sevenfold over the basal concentration. Hepatic glucose cycling comprised 15% +/- 4% of basal glucose turnover and increased more than 100% in response to isolated hyperglucagonemia. The increase in liver glucose cycling was observed also when serum insulin concentrations were increased sevenfold above baseline. Thus, we were able to induce dissociation of the activation of hepatic glucose cycling and the thermogenic response induced by hyperglucagonemia. From the quantitative point of view, the thermogenic cost of the cycles was less than 1% in both the basal and stimulated state. Thus, we concluded that hepatic glucose cycles play a quantitatively minor role in EE in man.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052138     DOI: 10.1016/0026-0495(94)90180-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

Review 1.  Minireview: Glucagon in stress and energy homeostasis.

Authors:  B J Jones; T Tan; S R Bloom
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

2.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  The alpha-cell as target for type 2 diabetes therapy.

Authors:  Mikkel Christensen; Jonatan I Bagger; Tina Vilsbøll; Filip K Knop
Journal:  Rev Diabet Stud       Date:  2011-11-10

4.  Contributions of gluconeogenesis to glucose production in the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 5.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 6.  The acute effect of glucagon on components of energy balance and glucose homoeostasis in adults without diabetes: a systematic review and meta-analysis.

Authors:  James Frampton; Chioma Izzi-Engbeaya; Victoria Salem; Kevin G Murphy; Tricia M Tan; Edward S Chambers
Journal:  Int J Obes (Lond)       Date:  2022-09-19       Impact factor: 5.551

Review 7.  New Developments in Glucagon Treatment for Hypoglycemia.

Authors:  LesleAnn Hayward Story; Leah M Wilson
Journal:  Drugs       Date:  2022-08-06       Impact factor: 11.431

Review 8.  Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?

Authors:  Ellen Conceição-Furber; Tamer Coskun; Kyle W Sloop; Ricardo J Samms
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

9.  Glucagon increases energy expenditure independently of brown adipose tissue activation in humans.

Authors:  V Salem; C Izzi-Engbeaya; C Coello; D B Thomas; E S Chambers; A N Comninos; A Buckley; Z Win; A Al-Nahhas; E A Rabiner; R N Gunn; H Budge; M E Symonds; S R Bloom; T M Tan; W S Dhillo
Journal:  Diabetes Obes Metab       Date:  2015-11-20       Impact factor: 6.577

Review 10.  A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Authors:  Ryan P Ceddia; Sheila Collins
Journal:  Clin Sci (Lond)       Date:  2020-03-13       Impact factor: 6.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.